Cyfuse Biomedical K.K.
株式会社サイフューズ
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4892
FY2025 · 2025-12-31
| Gross margin | 49.3% |
| Operating margin | -358.5% |
| Net margin | -330.7% |
| Return on equity | — |
| Return on assets | -17.9% |
| Revenue growth (YoY) | 324.3% |
| EPS (basic) | ¥-86.78 |
| EPS growth (YoY) | — |
| Current ratio | 4.54x |
| Equity ratio | 62.3% |
| Book value / share | ¥276.42 |
| Free cash flow | -582 M |